Baxter ROA 2006-2018 | BAX

Current and historical return on assets (ROA) values for Baxter (BAX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Baxter ROA for the three months ending December 31, 2018 was 9.93%.
Baxter ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-12-31 $1.62B $0.00B 12.91%
2018-09-30 $1.21B $16.85B 7.15%
2018-06-30 $0.91B $16.58B 5.36%
2018-03-31 $0.83B $16.89B 4.87%
2017-12-31 $0.72B $17.11B 4.26%
2017-09-30 $1.03B $17.54B 6.28%
2017-06-30 $0.91B $16.96B 5.69%
2017-03-31 $1.86B $15.66B 11.79%
2016-12-31 $4.97B $15.55B 30.71%
2016-09-30 $4.93B $15.80B 28.12%
2016-06-30 $4.80B $15.98B 25.77%
2016-03-31 $3.92B $17.35B 17.71%
2015-12-31 $0.97B $20.96B 4.03%
2015-09-30 $1.72B $20.17B 6.78%
2015-06-30 $2.18B $30.02B 8.19%
2015-03-31 $2.37B $24.86B 9.28%
2014-12-31 $2.50B $26.14B 9.74%
2014-09-30 $1.87B $25.56B 7.36%
2014-06-30 $1.95B $25.63B 7.68%
2014-03-31 $2.02B $25.26B 8.11%
2013-12-31 $2.01B $25.22B 8.51%
2013-09-30 $2.18B $25.25B 9.72%
2013-06-30 $2.22B $23.75B 10.53%
2013-03-31 $2.29B $20.32B 11.60%
2012-12-31 $2.33B $20.39B 12.01%
2012-09-30 $2.30B $19.83B 12.06%
2012-06-30 $2.29B $18.45B 12.34%
2012-03-31 $2.24B $18.78B 12.21%
2011-12-31 $2.22B $19.07B 12.34%
2011-09-30 $2.18B $17.84B 12.39%
2011-06-30 $2.13B $17.74B 12.15%
2011-03-31 $2.05B $17.41B 11.91%
2010-12-31 $1.42B $17.49B 8.27%
2010-09-30 $1.57B $17.56B 9.15%
2010-06-30 $1.57B $16.49B 9.26%
2010-03-31 $1.63B $17.17B 9.68%
2009-12-31 $2.21B $17.35B 13.57%
2009-09-30 $2.20B $16.95B 13.97%
2009-06-30 $2.14B $15.74B 13.99%
2009-03-31 $2.10B $14.95B 13.77%
2008-12-31 $2.01B $15.41B 13.19%
2008-09-30 $1.92B $15.21B 12.62%
2008-06-30 $1.85B $15.47B 12.33%
2008-03-31 $1.73B $14.97B 11.73%
2007-12-31 $1.71B $15.29B 11.66%
2007-09-30 $1.66B $14.15B 11.46%
2007-06-30 $1.64B $14.66B 11.36%
2007-03-31 $1.52B $14.48B 10.82%
2006-12-31 $1.40B $14.69B 10.27%
2006-09-30 $1.26B $13.93B 9.59%
2006-06-30 $1.00B $13.01B 7.64%
2006-03-31 $1.01B $12.78B 7.65%
2005-12-31 $0.96B $12.73B 7.09%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $39.448B $11.127B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $132.673B 26.23
Medtronic (MDT) Ireland $124.635B 18.20
Stryker (SYK) United States $69.927B 25.67
Boston Scientific (BSX) United States $55.591B 27.10
Zimmer Biomet Holdings (ZBH) United States $25.289B 16.23
Smith & Nephew SNATS (SNN) United Kingdom $16.755B 0.00
ResMed (RMD) United States $14.297B 27.11
Canopy Growth (CGC) Canada $10.742B 0.00
Bio-Rad Laboratories (BIO) United States $8.172B 52.25
Aurora Cannabis (ACB) Canada $7.060B 50.50
Hill-Rom Holdings (HRC) United States $6.958B 21.52
Perrigo (PRGO) Ireland $6.649B 10.09
ICU Medical (ICUI) United States $5.184B 28.88
Insulet (PODD) United States $5.071B 0.00
Haemonetics (HAE) United States $4.540B 40.28
GW Pharmaceuticals (GWPH) United Kingdom $4.400B 0.00
Agios Pharmaceuticals (AGIO) United States $3.380B 0.00
Hutchison China MediTech (HCM) China $3.329B 0.00
Neogen (NEOG) United States $3.267B 50.18
NuVasive (NUVA) United States $2.850B 24.96
Quidel (QDEL) United States $2.761B 24.91
National Vision Holdings (EYE) United States $2.637B 51.01
Aphria (APHA) $2.539B 112.78
NxStage Medical (NXTM) United States $2.000B 0.00
AtriCure (ATRC) United States $1.274B 0.00
HEXO (HEXO) $1.242B 0.00
Cardiovascular Systems (CSII) United States $1.240B 890.25
Phibro Animal Health (PAHC) United States $1.220B 17.53
VAREX IMAGING (VREX) United States $1.212B 23.73
MacroGenics (MGNX) United States $0.939B 0.00
Cerus (CERS) United States $0.904B 0.00
PetIQ (PETQ) United States $0.867B 22.47
Lantheus Holdings (LNTH) United States $0.847B 22.95
Surmodics (SRDX) United States $0.785B 114.20
Meridian Bioscience (VIVO) United States $0.733B 21.85
NanoString Technologies (NSTG) United States $0.721B 0.00
OraSure Technologies (OSUR) United States $0.720B 31.76
Omeros (OMER) United States $0.719B 0.00
Evolus (EOLS) United States $0.705B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.647B 20.75
LeMaitre Vascular (LMAT) United States $0.603B 28.76
Quanterix (QTRX) United States $0.518B 0.00
Insys Therapeutics (INSY) United States $0.426B 0.00
Owens & Minor (OMI) United States $0.408B 5.65
TG Therapeutics (TGTX) United States $0.398B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.99
BioLife Solutions (BLFS) United States $0.329B 445.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.294B 0.00
Vapotherm (VAPO) United States $0.288B 0.00
Bovie Medical (APYX) United States $0.282B 0.00
Rockwell Medical (RMTI) United States $0.262B 0.00
Cytosorbents (CTSO) United States $0.256B 0.00
Zynex (ZYXI) United States $0.174B 16.84
Fonar (FONR) United States $0.144B 7.70
Surface Oncology (SURF) United States $0.140B 0.00
Chembio Diagnostics (CEMI) United States $0.112B 0.00
Chimerix (CMRX) United States $0.100B 0.00
United-Guardian (UG) United States $0.090B 18.77
Female Health (VERU) United States $0.084B 0.00
InfuSystems Holdings (INFU) United States $0.078B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 18.20
Conatus Pharmaceuticals (CNAT) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Neurotrope (NTRP) United States $0.034B 0.00
Senestech (SNES) United States $0.021B 0.00
Myomo (MYO) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.014B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 14.14